Loading news...
Loading news...
Series D funding round for Revance Therapeutics raising $45M in June 2011
Series D funding round for Revance Therapeutics raising $45M in June 2011
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$284M
Top Valuation
-
Revance Therapeutics raised $45M in a Series D round.
The round was announced on 06/01/11.